Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
Abstract Background Whether a sequential or concurrent regimen of anthracyclines and taxanes is superior for breast cancer is controversial. We compared the efficacy of two regimens in patients with operable breast cancer based on all relevant published data of phase III randomized controlled trials...
Main Authors: | Wanjing Chen, Qian Tu, Yanfei Shen, Kejun Tang, Mengying Hong, Yong Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-021-02150-4 |
Similar Items
-
Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01) -
Assessment of pulmonary toxicities in breast cancer patients undergoing treatment with anthracycline and taxane based chemotherapy and radiotherapy- a prospective study
by: Aramita Saha, et al.
Published: (2013-12-01) -
ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
by: Tarek M. A. Abdel-Fatah, et al.
Published: (2019-08-01) -
Oral vinorelbine: its role in advanced breast cancer pre-treated with anthracycline and taxane chemotherapies
by: Fausto Petrelli, et al.
Published: (2011-12-01) -
New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
by: E V Artamonova, et al.
Published: (2013-06-01)